TD Cowen Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Maintains Target Price $35

Futu NewsJan 21 23:31 · Ratings

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireJan 18 05:05

Express News | ACADIA Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsJan 18 05:05

A Quick Look at Today's Ratings for ACADIA Pharmaceuticals(ACAD.US), With a Forecast Between $19 to $39

Futu NewsJan 15 21:00 · Ratings

Shareholders in ACADIA Pharmaceuticals (NASDAQ:ACAD) Have Lost 60%, as Stock Drops 4.0% This Past Week

Simply Wall StJan 15 18:59

Bank of America Securities Reaffirms Their Hold Rating on ACADIA Pharmaceuticals (ACAD)

TipRanksJan 15 18:17 · Ratings